CytoDyn Secures $5 Million Private Placement for Leronlimab Development
CytoDyn (CYDY) has announced that an anonymous private investor has contributed an additional $5 million through a private placement. This capital injection is specifically earmarked to support the ongoing clinical development programs for leronlimab, the company's lead drug candidate. The investment comes from a repeat investor who previously provided funding to the biotechnology firm. This infusion of liquidity provides CytoDyn with additional runway to advance its clinical trials and research initiatives related to its primary therapeutic assets.
Tickers: $CYDY
Topics: capital infusion clinical development private investment